Replimune Group, Inc. · NASDAQ:REPL
Xynos Konstantinos received 50,000 Replimune Group, Inc. shares as an award (Form 4)
Traded Apr 1, 2026 · Filed Apr 7, 2026
On Apr 1, 2026, Xynos Konstantinos (Chief Medical Officer) received 50,000 Replimune Group, Inc. shares as an award, leaving 249,685 shares. Filed Apr 7, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 249,685 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Award | 50,000 | 249,685 | Direct |
Source
Related
- Replimune Group, Inc.
- Xynos Konstantinos
- Replimune Group, Inc. shareholders
- Form 4 · Xynos Konstantinos · Nov 18, 2026
- Form 4 · Xynos Konstantinos · Aug 12, 2026
- Form 4 · Xynos Konstantinos · May 20, 2026
- Form 4 · Schwendenman Andrew · Nov 18, 2026
- Form 4 · Patel Sushil · Nov 18, 2026
- Form 4 · Hill Emily Luisa · Nov 18, 2026
- Schedule 13G/A · Rtw Investments, LP · Nov 16, 2026
- Form 4 · Slattery Joseph P · Nov 10, 2026